Table 2. Outcomes of the base case scenario and the scenario of patients with allergic asthma and allergic rhinitis                                                                                                                                                                               
Outcomes AA AA AA AA + AR AA + AR AA + AR
   SCIT + ICS  ICS  Difference  SCIT + ICS  ICS  Difference
Pediatric patients            
Clinical outcomes            
  Total number of ED visits 733 1,152 -419 485 1,743 -1258
  Total number of hospitalizations 736 1,165 -428 487 1,762 -1275
  Total QALYs 6,794 6,420 374 6,807 6,389 418
Cost outcomes (discounted)            
Health states
  GINA Step 3 1,137,087 346,364 790,724 1,218,917 443,452 775,465
  GINA Step 2 129,390 36,345 93,045 141,547 41,758 99,789
  Asthma without medications 42,297 14,470 27,828 42,297 14,470 27,828
Events
  ED visits 16,907 26,569 -9,662 11,178 40,188 -29,010
  Hospitalizations 112,048 177,203 -65,155 74,077 268,036 -193,959
Total costs 1,437,731 600,950 836,780 1,488,016 807,903 680,113
Adult patients            
Clinical outcomes            
  Total number of ED visits 731 1,148 -417 483 1,736 -1253
  Total number of hospitalizations 734 1,160 -427 485 1,755 -1270
  Total QALYs 6,768 6,396 372 6,781 6,365 416
Cost outcomes (discounted)            
Health states
  GINA Step 3 1,195,697 416,656 779,041 1,277,246 513,388 763,858
  GINA Step 2 138,093 41,269 96,824 150,202 46,662 103,540
  Asthma without medications 42,104 14,404 27,699 42,104 14,404 27,699
Events
  ED visits 16,964 26,654 -9,690 11,215 40,317 -29,101
  Hospitalizations 111,835 176,822 -64,987 73,936 267,459 -193,524
Total costs 1,504,693 675,805 828,888 1,554,704 882,231 672,473